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Abstract
Background: Porphyria cutanea tarda (PCT) is caused by hexachlorobenzene (HCB) in several
species of laboratory mammals, but the human evidence is contradictory. In a study among adults
of a population highly exposed to HCB (Flix, Catalonia, Spain), the prevalence of PCT was not
increased. We aimed at analysing the association of individual urinary porphyrins with the serum
concentrations of HCB and other organochlorine compounds in this highly exposed population.
Methods: A cross-sectional study on total porphyrins was carried out in 1994 on 604 inhabitants
of the general population of Flix, older than 14 years. Of them, 241 subjects (comprising a random
sample and the subgroup with the highest exposure) were included for the present study. The
porphyrin profile was determined by high-pressure liquid chromatography. Serum concentrations
of HCB, as well as common organochlorine compounds, were determined by gas chromatography
coupled to electron capture detection.
Results: Coproporphyrin I (CPI) and coproporphyrin III (CPIII) were the major porphyrins
excreted, while uroporphyrins I and III were only detected in 2% and 36% of the subjects
respectively, and heptaporphyrins I and III in 1% and 6%, respectively. CPI and CPIII decreased with
increasing HCB concentrations (p < 0.05). This negative association was not explained by age,
alcohol, smoking, or other organochlorine compounds. No association was found between
uroporphyrin I and III excretion, nor heptaporphyrin excretion, and HCB. CPIII increased with
smoking (p < 0.05).
Conclusion:  HCB exposure in this highly exposed population did not increase urinary
concentrations of individual porphyrins.
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The porphyrias are disorders of the haem biosynthesis in
which specific patterns of overproduction of haem precur-
sors are associated with particular clinical features. Por-
phyria cutanea tarda (PCT) is one of the major potential
toxic manifestations of hexachlorobenzene (HCB) in sev-
eral species of laboratory mammals [1]. However, the por-
phyrinogenic effect of this chemical on humans has not
been widely studied. The first cases of PCT induced by
HCB in humans were reported in south-eastern Turkey in
the late 1950s due to food poisoning in undernourished
children [2–4]. Levels of HCB were not measured. In ad-
dition, there have been some case reports of workers ex-
posed to HCB developing PCT [5], but there was no
association between exposure to HCB and PCT in small
studies in workers [6–8].
High atmospheric levels of HCB (mean 35 µg/m3) were
detected in Flix (Catalonia, Spain), a village of 5,000 in-
habitants located in the vicinity of an electrochemical fac-
tory, the only industry in town [9]. Internal dose
concentrations (i.e., serum) found were the highest ever
reported in human general populations [10]. In a survey
of 604 inhabitants only one subject had abnormally high
levels of total porphyrins, compatible with PCT [11], re-
sulting in a prevalence of PCT not higher than expected
[12]. The association between individual urinary porphy-
rins and the internal dose of HCB was studied only in the
15 subjects with extremely high levels of HCB. Although
concentrations of total porphyrins were within the range
of clinical normality in this adult population [11], varia-
tions within the normality could be informative of sub-
clinical harmful effects (i.e., functional effects). In
addition, functional effects may be applied to risk assess-
ment and prevention for its potential impact on suscepti-
ble populations [13].
Our objective was to determine the association between
individual urinary porphyrin levels and serum concentra-
tions of HCB and other organochlorine compounds in the
general population of Flix.
Material & Methods
Study population
An epidemiological cross-sectional study was carried out
on the 4,178 inhabitants of Flix older than 14 years in
1994 and details of participation and sociodemographic
characteristics are described elsewhere [14]. Total porphy-
rins were analysed in 604 of these participants [11], a sub-
sample of 241 of them being included in the present
study. This subsample was composed of a 100 subjects
previously selected for the studies of HCB biokinetics [15]
consisting of those 8 subjects with the four highest and
four lowest HCB levels, complemented by a random sam-
ple of 92, supplemented by a further 141 subjects who
had worked in the electrochemical factory. Workers were
included because they had the highest levels of HCB in
Flix [10]. In total, 177 out of the 241 subjects had worked
in the electrochemical factory at some time, of whom 55
were currently employed. The individual with PCT was ex-
cluded from this analysis. All subjects were informed of
the purpose of the study and signed a written consent
form approved by the ethical committee at IMIM.
Urinary porphyrin measurements
Urine samples (24 h) were collected in 2 L plastic flasks.
Immediately after collection, sodium bicarbonate was
added to obtain a solution of 5 g/L, and 5 ml aliquots
were transferred to polypropylene tubes and stored at -
20°C until analysis. All urine specimens were analysed
without previous knowledge of HCB levels in serum. Uri-
nary porphyrin excretion patterns were analysed by high
performance liquid chromatography (HPLC). Briefly, 1
mL of urine sample was acidified with 50 µL of HCl and
200 µL of this solution was injected. The HPLC determi-
nation was performed with Waters equipment (Waters
Corp. Mildford, MA, USA) (2 pumps mod. 515, an au-
tosampler injector (mod. 717 plus) and Millennium soft-
ware). The porphyrins were detected using a fluorescence
detector (mod. 474), under the following conditions: ex-
citation 405 nm, emission 618 nm, both with band
widths of 18 nm. Porphyrin separation was achieved with
an analytical column BDS-Hypersil (250 ×  4.6 mm, 5 µm
particle size) (Shandon HPLC, Cheshire, U.K) and a gra-
dient from 100% of solvent A (10:90 acetonitrile/ammo-
nium acetate 1 M pH 5.16) to 95% of solvent B (10:90
acetonitrile/methanol) in 25 min. The flow rate was 1.2
mL/min [16].
Analysis of organochlorine compounds
Organochlorine compounds in serum were analysed by
gas chromatography (GC) coupled to electron capture de-
tection and GC coupled to chemical ionisation negative-
ion mass spectrometry. A Varian Star 3400 coupled to a
Finnigan Mat INCOS XL was used for the analyses. All the
analyses were carried out in the Department of Environ-
mental Chemistry (CID-CSIC). Details of the methodolo-
gy have been reported elsewhere [10,15]. We present
results for the most prevalent compounds found in sera
samples: HCB, dichlorodiphenyl dichloroethene (p,p'-
DDE), and polychlorinated biphenyls (PCBs) which we
present as the summation of the individual congeners 28,
52, 101, 118, 138,153, and 180. Because the PCB conge-
ners 138, 153 and 180 represented around 90% of total
PCBs, we also provide results of these individual conge-
ners. Detection limits for HCB and p,p'-DDE were 0.2 ng/
mL, and for the individual congeners of PCBs were the fol-
lowing: 0.17, 0.15, 0.09, 0.11, 0.15, 0.12, and 0.10. The
concentration of organochlorine compounds below the
detection limit were set at half the limit of detection.Environmental Health: A Global Access Science Source 2002, 1 http://www.ehjournal.net/content/1/1/1
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Statistical analysis
Individual porphyrins were treated both as a dichoto-
mous variable (detectable/non-detectable) and as contin-
uous variable after assigning half the detectable level to
represent the non-detectable values. Total porphyrins
were analysed only as a continuous variable since all ob-
servations were detectable, while uroporohyrins were an-
alysed only as a dichotomous variable since most of the
observations were not-detectable. The crude association
between porphyrins and the study variables (organochlo-
rine compounds as well as confounding variables such
age, sex, alcohol, smoking and duration of the residence)
was assessed with the non-parametric Wilcoxon test for
linear trend, given the non-normal distribution of por-
phyrins. To control the association between porphyrins
and organochlorine compounds for the confounding var-
iables both linear regression models and logistic regres-
sion models were fitted. Since the data distribution of
individual porphyrins was skewed, a logarithmic transfor-
mation was carried out. Organochlorine compounds were
treated both as trichotomous variables and as continuous
variables, given a certain linearity in the association with
porphyrins. Organochlorine compounds were also loga-
rithmically transformed (in base 10) to achieve a normal
distribution. Multiple linear regression analysis was per-
formed to examine the relationship between continuous
values of porphyrins (total porphyrins, CP I, CPIII) and
organochlorine levels adjusting for potential confounding
variables such as creatinine in serum [14]. Association was
measured with the regression coefficient. The antiloga-
rithm of the coefficient yields the relative change in por-
phyrin levels for each 10-fold increase in organochlorine
compound levels. Multiple logistic regression models
were fitted to estimate the adjusted association between
categorical values of uroporophyrins I and III and organ-
ochlorine compounds. The measure of association was
the odds ratio. Statistical significance was defined as p <
0.05. All statistical analyses were performed using Stata
(StataCorp. TX, USA).
Table 1: Characteristics of the 241 subjects
Variable n (%)
Male 180 (75)
Age
< 45 years 89 (37)
45–64 years 84 (35)
> 64 years 68 (28)
Alcohol
No 73 (30)
Occasional 61 (25)
Habitual (> 3 drinks a week) 107 (45)
Smoking
Never 73 (30)
Occasional 11 (5)
Ex 82 (34)
Current 75 (31)
<20 cigs./day 33 (13)
≥  20 cigs./day 42 (18)
Years living in Flix
1–9 4 (2)
10–19 19 (8)
>20 218 (90)
Table 2: Distribution of urinary uroporphyrines (µmol/L) and serum concentrations of organochlorinated compounds (ng/mL) (n = 241 
subjects)
% detectable Percentiles among detectables
Min p25 p50 p75 Max
Total porphyrins 100% 13.0 63.8 98.5 157 497
Uro I 36% 2.0 6.0 10.0 16.0 37.0
Uro III 2% 1.0 1.0 1.0 8.0 8.0
Hepta I 1% 2.0 2.0 2.5 3.0 3.0
Hepta III 6% 2.0 2.8 4.0 6.8 13.0
Copro I 76% 1.0 4.0 7.0 14.0 134
Copro III 86% 2.0 10.0 21.5 37.0 154
HCB 100% 2.30 13.2 21.7 37.9 1616
DDE 97% 0.1 2.59 6.15 14.4 67.4
Total PCBs† 94% 0.2 1.89 3.78 7.02 143
CB-138 87% 0.1 0.58 1.03 1.85 35.0
CB-153 85% 0.1 0.67 1.18 2.32 40.9
CB-180 89% 0.1 0.58 1.43 2.66 63.5
Uro: uroporphyrins; Hepta: heptaporphyrins; Copro: coproporphyrins. † PCBs = Σ  (28, 52, 101, 118, 138, 153, 180) congenersEnvironmental Health: A Global Access Science Source 2002, 1 http://www.ehjournal.net/content/1/1/1
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Results
Table 1 presents the socio-demographic and behavioural
characteristics of the subjects included in this study. Not
surprisingly, most of them are males given that we en-
riched the sample with the electrochemical workers in or-
der to have the individuals with the highest HCB levels in
the study. It is noticeable that most of them had lived in
the town for more than 20 years.
Distributions of total porphyrin concentrations and indi-
vidual urinary porphyrins as well as organochlorine com-
pound levels in serum are presented in table 2.
Coproporphyrin isomers I-III (CPI; CPIII) were the major
porphyrins excreted. The uroporphyrin I (UPI) fraction
was the third most excreted porphyrin. The heptacarboxy-
lporphyrin isomer I (hepta I) was only detected in 1% of
subjects and the heptaporphyrin isomer III (hepta III) in
6%. The hexa- and pentacarboxylporphyrin fractions were
not detected. Among the organochlorine compounds, all
subjects had detectable concentrations of HCB, and most
of them of p,p'-DDE. The highest concentrations were
found for HCB. The most prevalent PCB congener was CB-
180.
Total porphyrins decreased with age, years of residence in
Flix, and organochlorine concentrations (except CB-153)
and increased with male gender and tobacco smoking, in
a statistically significant way, while no association was ob-
served with alcohol consumption (table 3). A similar pat-
tern was observed with CPI and CPIII, except that the
association with sex disappeared. However, for CPI the
only statistically significant differences found were for
age, years of residence, HCB and p,p'-DDE, but not for
smoking or PCBs. For CPIII, the associations with smok-
ing and PCBs, in addition to age, years of residence, HCB
and p,p'-DDE, were significant. The negative association
of CPI and CPIII with HCB occurred both in subjects
working in the electrochemical factory (with the highest
HCB levels, median of HCB = 79.2 ng/mL) and in non-
workers (median HCB = 14.2 ng/mL). Workers had lower
average levels of CPIII than non-workers (20.6 and 33.3
µmol/L, respectively) and of CPI (6.8 and 11.2 µmol/L, re-
spectively) (all p < 0.05). UPI and UPIII did not differ for
any of the study variables (table 3), and nor did heptapor-
phyrin.
The negative association of HCB with total porphyrins
and CPIII remained after adjusting for the confounding
variables (table 4). The association between HCB and CPI
was also negative but with a p value of 0.06. When HCB
was treated as a trichotomous variable in the multivariate
models, results were very similar to those in table 3
(where they were unadjusted), with a p value < 0.05 for
CPIII. In contrast, the associations of p,p'-DDE and PCBs
disappeared in the multivariate model. HCB remained as-
sociated with total porphyrins and CPIII after adjusting
for p,p'-DDE and PCBs. In the multivariate models, the
positive associations of smoking with total porphyrins
(coefficient (se) = 0.18 (0.08)), and mainly with CPIII
(coefficient (se) = 0.30 (0.13)) remained, and so did the
negative association of age with total porphyrins, CPI and
CPIII. The adjusted association with UPI and UPIII re-
mained non-significant.
Discussion
In experimental porphyria in laboratory animals, intake
of HCB was followed initially by a moderate increase of
coproporphyrins, and later by an increase of highly car-
boxylated porphyrins, such as uroporphyrins and hep-
taporphyrins [17]. In our human population, we observed
that levels of individual urinary porphyrins (uropophy-
rins, heptaporphyrins, coproporphyrins) did not increase
with serum HCB concentrations. Even though our results
contrast with the findings to be expected from experi-
ments in animals [17], in general, they coincide with old-
er studies in human populations (table 5) since no
increase of uroporphyrins was observed in any of these
studies. In addition, in contrast with animals, copropor-
phyrins (mainly CPIII) were lower in subjects with higher
levels of HCB which agrees with an old study in workers
from a chlorinated solvents plant [8]. Furthermore, ne-
onates of Flix also showed a decrease of coproporhyrins in
relation to HCB [18], although levels of urinary porphy-
rins during the first 10 days of life are highly variable [19],
and results difficult to interpret. The negative association
with coproporphyrins was not found in a cross-sectional
study in the general population in Louisiana, USA [20],
where plasma concentrations of HCB were positively cor-
related with levels of urinary coproporphyrin, though in a
weak and crude way (correlation coefficient = 0.15. How-
ever, serum concentrations of HCB among these subjects
were very low in contrast with spray workers from the
same location among whom there was no association be-
tween HCB and individual coproporphyrins [7]. Finally,
in a study comparing 9 smelter workers exposed to HCB
and to octachlorostyrene with 18 non-exposed workers,
CPIII was higher among the workers [21]. Only this latter
study, in addition to the studies conducted in Flix, meas-
ured the porphyrin profile using a reliable method such as
the high-pressure liquid chromatography. However, the
authors did not report the levels of HCB, and comparisons
were not adjusted for other variables related with porphy-
rins such as age and smoking.
Epidemiological studies on porphyrins with other envi-
ronmental agents are rare. The possible role of other hal-
ogenated compounds, such as dioxins (TCDD), in the
disturbance of the porphyrin metabolism was proposed
due to some case reports of PCT among workers [22].
However, this effect was mostly attributed to a concomi-Environmental Health: A Global Access Science Source 2002, 1 http://www.ehjournal.net/content/1/1/1
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Table 3: Association between urinary porphyrine concentrsations and the study variables (age, sex, alcohol, smoking, years of residence, 
and organochlorintaed compounds in serum).
TP Copro I Copro III Uro I + UroIII
Median 
(25%–75%)
Detectables n 
(%)
Median 
(25%-75%) †
Detectables n 
(%)
Median 
(25%-75%) †
Detectables n 
(%)
Age
<45 117 (73–185) 70 (79) 7 (3–15) 85 (96) 29 (11–46) 31 (35)
45–64 89 (62–132) 62 (74) 4 (0.5–8) 67 (80) 14 (4.5–27.5) 24 (29)
>64 83 (56–126)* 51 (75) 4 (1.3–9)* 56 (82)* 12.5 (3–30)* 27 (40)
Sex
Female 85 (62–112) 42 (69) 5 (0.5–11) 60 (98) 20 (10–31) 17 (28)
Male 107 (65–165)* 141 (78) 5 (2–11) 148 (82)* 19 (5–37) 65 (36)
Alcohol
No 99 (62–144) 52 (71) 5 (0.5–11) 67 (92) 18 (6–35) 23 (32)
Ocasional 86 (64–143) 45 (74) 5 (0.5–10) 52 (85) 19 (7–35) 21 (34)
Habitual 103 (66–162) 86 (80) 5 (3–12) 89 (83) 20 (5–35) 38 (36)
Smoking
Never 86 (62–124) 52 (71) 5 (0.5–10) 64 (88) 19 (6–29) 19 (26)
Ocasional + Ex 92 (60–146) 65 (70) 4 (0.5–10) 76 (82) 12 (4–35) 33 (35)
< 20 cigs./day 103 (83–159) 30 (91) 6 (4–9) 28 (85) 20 (7–39) 12 (36)
≥  20 cigs./day 127 (81–588)* 36 (86)* 6.5 (3.5–15) 40 (95) 32 (12–46)* 18 (43)
Years living in Flix
≤  20 years 165 (86, 240) 21 (91) 7 (3, 19) 22 (95) 27 (17,51) 10 (43)
> 20 years 94 (62, 143)* 162 (74) 5 (0.5, 10)* 186 (85) 19 (6, 34)* 72 (33)
HCB ng/ml (tertiles)
<16.1 129 (81–176) 60 (77) 7 (2–15) 73 (94) 26 (8–43) 29 (37)
16.1–29.5 82 (55–126) 62 (75) 4 (0.5–10) 70 (84) 18 (5–31) 28 (34)
>29.5 92 (64–130)* 61 (76) 5 (2–8.5)* 65 (81)* 14 (5–31.5)* 25 (31)
DDE ng/ml (tertiles)
< 3.22 124 (74–179) 62 (78) 7 (2–15) 74 (94) 26 (7–49) 31 (39)
3.22 – 9.88 105 (65–161) 60 (75) 4 (0.5–10) 64 (80) 20 (4.5–35) 22 (28)
> 9.88 82 (57–117)* 61 (74) 5 (2–8.5)* 70 (85) 12 (5–26)* 29 (35)
PCBs ng/ml (tertiles)
< 2.08 108 (74, 166) 63 (80) 6 (2–13) 72 (91) 22 (7, 35) 21 (27)
2.08–4.89 99 (61, 172) 60 (77) 4 (2–12) 69 (88) 20 (6, 38) 30 (38)
> 4.89 87 (59, 130)* 60 (73) 4.5 (0.5–9) 67 (80)* 13.5 (4, 30)* 31 (37)
CB-138 (tertiles)
< 0.55 108 (73–116) 63 (79) 5.5 (2.5–13) 73 (91) 20 (7.5–36.5) 19 (24)
0.55 – 1.29 99 (61–146) 63 (80) 5 (2–12) 69 (87) 21 (6–38) 36 (46)
> 1.29 89 (60–130)* 57 (70) 4 (0.5–9) 66 (80)* 13 (4–29)* 27 (33)
CB-153 (tertiles)
< 0.61 109 (73–161) 65 (81) 6 (3–13.5) 74 (93) 21 (8.5–35) 21 (26)
0.61 – 1.36 98 (61–173) 58 (73) 4 (0.5–11) 66 (84) 20 (5–39) 30 (38)
> 1.36 87 (61–130) 60 (73) 4 (0.5–9)* 68 (83) 13 (5–32) 31 (38)
CB-180 (tertiles)
< 0.61 110 (73–168) 64 (80) 5 (2–11.5) 72 (90) 21 (7–38.5) 22 (28)
0.61 – 1.80 94 (61–143) 59 (75) 5 (0.5–12) 73 (92) 20 (6–37) 26 (33)
> 1.80 90 (60–141)* 60 (73) 4.5 (0.5–10) 63 (77)* 14 (3–29)* 34 (41)
TP: total porphyrins; CPI, CPIII: coproporphyrins I, III; UPI, UPIII: uroporphyrins I, III. * p < 0.05 using the extension of the non-parametric Wil-
coxon test for linear trend † non-detectable values were set at the median value between 0 and the detectable levelEnvironmental Health: A Global Access Science Source 2002, 1 http://www.ehjournal.net/content/1/1/1
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tant exposure to HCB [22]. Recent epidemiological stud-
ies in human populations did not find any association of
TCDD exposure with regard to urinary uroporphyrin or
coproporphyrin levels [23,24]. A negative association be-
tween arsenic concentration in urine and CPIII was found
in 36 individuals from the general population in an area
of Mexico with high levels of arsenic in drinking water
compared with 31 non-exposed subjects [25]. In contrast
with studies on HCB, a concomitant increase in uropor-
phyrins occurred. Also, in a crossectional study carried out
in a convention of dentists, the 38 dentists with levels of
total mercury higher than 20 µg/l had higher levels (twice)
of urinary coproporphyrins than the 23 dentists with no
detectable levels of mercury [26]. Mechanisms of action
for these compounds, however, could be of a different na-
ture than those related with HCB.
In accordance with our previous observation of an associ-
ation of passive smoking with CPIII in neonates [18], ac-
tive smoking is associated with an increase of porphyrins
in the present study. In patients with intermittent porphy-
ria, smoking was associated with induction of repeated
Table 4: Adjusted association between urinary porhyrin levels and serum concentrations of organochlorinated compounds (n = 241).
Organochlorinated compound TP Copro I Copro III
Coefficient (se)†
Single pollutant model
HCB -0.265 (0.078)* -0.321 (0.171) -0.395 (0.187)*
DDE -0.024 (0.049) 0.048 (0.115) -0.051 (0.123)
PCBs -0.005 (0.048) -0.039 (0.111) -0.019 (0.120)
Multipollutant model††
HCB -0.281 (0.079)* -0.315 (0.174) -0.420 (0.190)*
DDE -0.056 (0.053) 0.039 (0.127) -0.092 (0.137)
PCBs 0.005 (0.052) -0.059 (0.121) -0.011 (0.131)
TP: Total porphyrins. CPI and CPIII: coproporphyrins, I and III, respectively. † The coefficient gives the relative change in prophyrin levels for a 10-
fold concentration increase in the organochlorinated compound., adjusted for age, smoking, alcohol, years of residence in Flix, and creatinine in 
serum. †† Adjusted for age, smoking, alcohol and years of residence in Flix, as well as for the other organochlorinated compounds in the table. * p 
< 0.05
Table 5: Studies on urinary porphyrins in human populations exposed to moderate levels of hexachlorobenzene (HCB).
Porphyrins
Author year/country (ref) N Period Serum-HCB 
(range in ng/mL)
UP CP Comments
WORKERS
Morley 1973/Australia [6] 54 1950's-60's NA NS NS only 1 worker with high 
UP
Burns 1974/USA [7] 20 1973–74 <1–310 NS NS -
Currier 1980/USA [8] 50 1974–7 3–1121 NS ↓↓  CP if HCB > 200
Selden 1999/Sweden [21] 27 1980's NA(9E/18NE) NS ↑↑  CPIII in E vs NE
GENERAL POPULATION
NEONATES
Ozalla 2002/Spain [18] 68 1997–99 0.4–21 NS ↓↓  CPI and CPIII
ADULTS
Burns 1975/USA [20] 120 1972 0–23 NS ↑ -
This study/Spain 242 1994 2–1616 NS ↓↓  CPI and CPIII
NA: not available. NS: no statistically significant difference. UP: uroporphyrins. CP, CPI and CPIII: coproporphyrins total, I and III. E/NE: number of 
subjects exposed/non-exposedEnvironmental Health: A Global Access Science Source 2002, 1 http://www.ehjournal.net/content/1/1/1
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acute attacks of porphyria [27]. This finding agrees with a
possible indirect effect of smoke through a cytochrome
P450 induction, since some P450 isoenzymes such as
P4501A2s, which is affected by smoking, are involved in
disturbances of porphyrin metabolism [28]. Recently it
has been suggested that HCB should be classified as a di-
oxin-like compound that binds the Aryl hydrocarbon
(Ah) receptor inducing hepatic cytochrome p4502B activ-
ity [29]. Why smoking is associated with an increase of
CPIII while HCB was associated with a decrease of CPI
and CPIII, without modifying uroporphyrin levels, is an
intriguing problem to solve.
Overall, the epidemiological studies in human popula-
tions have to be considered with caution given their size,
the methodology used to measure the porphyrin profile,
the control of the effect of variables such as age and smok-
ing and the difficulties in disentangling the individual
pollutant effects from the pollution mixtures. A conclu-
sion from such review is the lack of a common procedure
in environmental studies of porphyria. In addition, por-
phyrin increases have been related with the multiple
chemical sensitivity syndrome (MCS) [13]. However,
there is currently no convincing evidence that MCS syn-
drome affects the haem synthesis [13]. Our findings con-
firm that it is premature and speculative to relate
porphyrin increases with current environmental expo-
sures.
The present results do not seem affected by a selection bias
given that similar findings were observed both in the ran-
dom and the enriched sample. Cross-sectional bias also
seems improbable since exposure to HCB could not be de-
termined by knowledge of levels of uroporphyrins and
viceversa. A confounding effect due to an unmeasured var-
iable seems also unlikely. Positive serology against virus C
was only found in 4 of the subjects, and renal dysfunction
was detected in a very small proportion [14]. A final expla-
nation could be the presence of an error due to misclassi-
fication of uroporphyrins or HCB levels, non-differential,
that led to the dilution of the association between HCB
and uroporphyrins. Nevertheless, an error of this type
should also have affected the association with smoking,
while a positive association with smoking was found. In
addition, in the present study porphyrin patterns and
HCB levels were determined with the best current technol-
ogy. These facts suggest that the effect of this misclassifica-
tion error if any must be small and unlikely to explain the
complete lack of porphyrin increase according to the cat-
egories of HCB.
The present study is the largest ever conducted, used a re-
liable method of measuring porphyrin patterns and incor-
porated analysis of cofactors. In addition, the population
under study is specifically exposed to high levels of HCB
(serum concentrations were around 20 times higher than
in unexposed Europeans of the same age [10], and levels
of other pollutants such as PCB, DDE or dioxins were
within the range of most populations [9]).
Conclusion
The present results suggest that current levels of HCB are
not associated with an increase of the individual uropor-
phyrins, and if anything are associated with a decrease of
the coproporphyrins, which challenges the concept of a
porphyrinogenic effect of environmental pollutants at
current levels of exposure.
Abbreviations
PCT Porphyria Cutanea Tarda
HCB Hexachlorobenzene
CPI Coproporphyrin I
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